广发医药健康混合C(010111)利润分配表
|
2024-12-31 |
2024-06-30 |
2023-12-31 |
2023-06-30 |
收入 |
-263,247,054.79 |
-365,023,325.45 |
-644,445,011.84 |
-512,740,086.08 |
利息合计 |
1,210,812.20 |
570,494.67 |
1,259,128.90 |
471,145.40 |
其中:存款利息收入 |
1,210,812.20 |
570,494.67 |
1,259,128.90 |
471,145.40 |
债券利息收入 |
- |
- |
- |
- |
资产支持证券利息收入 |
- |
- |
- |
- |
买入返售金融资产收入 |
- |
- |
- |
- |
投资收益合计 |
-425,743,794.94 |
-285,545,799.69 |
-925,341,429.41 |
-673,981,894.36 |
其中:股票投资收益 |
-448,604,665.79 |
-300,305,230.24 |
-948,146,998.08 |
-689,866,394.96 |
基金投资收益 |
- |
- |
- |
- |
债券投资收益 |
232,282.17 |
232,282.17 |
10,903.32 |
10,903.32 |
资产支持证券投资收益 |
- |
- |
- |
- |
衍生工具收益 |
- |
- |
- |
- |
股利收益 |
22,628,588.68 |
14,527,148.38 |
22,794,665.35 |
15,873,597.28 |
基金分红收益收益 |
- |
- |
- |
- |
公允价值变动收益 |
160,947,504.74 |
-80,212,217.62 |
278,315,808.78 |
159,717,635.93 |
其他收入 |
338,423.21 |
164,197.19 |
1,321,479.89 |
1,053,026.95 |
费用 |
35,011,689.12 |
17,681,220.50 |
51,867,490.66 |
30,541,282.56 |
管理人报酬 |
26,680,684.26 |
13,481,927.90 |
40,123,304.91 |
23,864,691.02 |
基金托管费 |
4,446,780.77 |
2,246,988.05 |
6,687,217.42 |
3,977,448.49 |
销售服务费 |
3,594,554.63 |
1,809,707.09 |
4,765,374.80 |
2,543,198.47 |
交易费用 |
- |
- |
- |
- |
利息支出 |
- |
- |
- |
- |
其中:卖出回购金融资产支出 |
- |
- |
- |
- |
其他费用 |
289,668.38 |
142,596.38 |
291,593.53 |
155,944.58 |
利润总额 |
-298,258,743.91 |
-382,704,545.95 |
-696,312,502.50 |
-543,281,368.64 |
欢迎访问证券之星!请点此与我们联系 版权所有: Copyright © 1996-年